Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
株式のランク #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
株価
$0.0009
最終同期: 2025-05-27
時価総額
$1.15K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Arch Therapeutics, Inc. (ARTH)

カテゴリー

Arch Therapeutics, Inc.(ARTH)のEPS
June 2024 時点のEPS TTM: $-2.86
Arch Therapeutics, Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-2.86です。2022年末には、EPSは$-3.56で、2021年のEPS$-5.97と減少でした。
Arch Therapeutics, Inc.のEPS履歴(2011から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-2.86 25.99%
2023 $-2.27 -36.24%
2022 $-3.56 -40.37%
2021 $-5.97 39.81%
2020 $-4.27 30.58%
2019 $-3.27 -48.10%
2018 $-6.30 -42.25%
2017 $-10.91 10.54%
2016 $-9.87 36.33%
2015 $-7.24 -70.00%
2014 $-24.13 114.11%
2013 $-11.27 766.92%
2012 $-1.30 1,424.03%
2011 $-0.09 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -705.59%
US
$27.74 -1,069.93%
NL
- -
CH
$13.70 -579.02%
BE
- -
KR